Brief: RTW Biotech Opportunities Says Obsidian Therapeutics To Merge With Galera
15/04/2026 07:49
April 15 (Reuters) - RTW Biotech Opportunities Ltd RTW.L: OBSIDIAN THERAPEUTICS REVERSE MERGER WITH GALERA OBSIDIAN THERAPEUTICS TO MERGE WITH GALERA VIA REVERSE MERGER REVERSE MERGER OCCURS WITH $350 MILLION PRIVATE PLACEMENT FINANCING NEW COMPANY EXPECTED TO BEGIN TRADING IN Q3 2026 NEW COMPANY TO TRADE ON NASDAQ UNDER TICKER SYMBOL 'OBX' ((Reuters.Briefs@thomsonreuters.com;;))